These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8094749)

  • 1. Repeated amphetamine administration: role of forebrain in reduced responsiveness of nigrostriatal dopamine neurons to dopamine agonists.
    Pitts DK; Kelland MD; Freeman AS; Chiodo LA
    J Pharmacol Exp Ther; 1993 Feb; 264(2):616-21. PubMed ID: 8094749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated stimulation of dopamine D2-like receptors: reduced responsiveness of nigrostriatal and mesoaccumbens dopamine neurons to quinpirole.
    Pitts DK; Wang L; Kelland MD; Freeman AS; Chiodo LA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):412-21. PubMed ID: 7562579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ontogeny of nigrostriatal dopamine neuron autoreceptors: iontophoretic studies.
    Wang L; Pitts DK
    J Pharmacol Exp Ther; 1995 Jan; 272(1):164-76. PubMed ID: 7815330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of (+)-4-propyl-9-hydroxynaphthoxazine on midbrain dopamine neurons: an electrophysiological study.
    Kelland MD; Freeman AS; LeWitt PA; Chiodo LA
    J Pharmacol Exp Ther; 1990 Oct; 255(1):276-84. PubMed ID: 1976800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloral hydrate anesthesia alters the responsiveness of identified midbrain dopamine neurons to dopamine agonist administration.
    Kelland MD; Freeman AS; Chiodo LA
    Synapse; 1989; 3(1):30-7. PubMed ID: 2919369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological and pharmacological characterization of identified nigrostriatal and mesoaccumbens dopamine neurons in the rat.
    Clark D; Chiodo LA
    Synapse; 1988; 2(5):474-85. PubMed ID: 2903568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SKF 38393 alters the rate-dependent D2-mediated inhibition of nigrostriatal but not mesoaccumbens dopamine neurons.
    Kelland MD; Freeman AS; Chiodo LA
    Synapse; 1988; 2(4):416-23. PubMed ID: 2973142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine neuron ontogeny: electrophysiological studies.
    Pitts DK; Freeman AS; Chiodo LA
    Synapse; 1990; 6(4):309-20. PubMed ID: 1981111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
    Jeziorski M; White FJ
    Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons.
    Kelland MD; Freeman AS; Chiodo LA
    J Pharmacol Exp Ther; 1990 May; 253(2):803-11. PubMed ID: 1971022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release.
    Robertson GS; Tham CS; Wilson C; Jakubovic A; Fibiger HC
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1344-51. PubMed ID: 8095550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
    Ruskin DN; Bergstrom DA; Walters JR
    J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anesthetic influences on the basal activity and pharmacological responsiveness of nigrostriatal dopamine neurons.
    Kelland MD; Chiodo LA; Freeman AS
    Synapse; 1990; 6(2):207-9. PubMed ID: 1978421
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization.
    Wolf ME; White FJ; Nassar R; Brooderson RJ; Khansa MR
    J Pharmacol Exp Ther; 1993 Jan; 264(1):249-55. PubMed ID: 8093727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated amphetamine: reduced dopamine neuronal responsiveness to apomorphine but not quinpirole.
    Pitts DK; Freeman AS; Kelland MD; Chiodo LA
    Eur J Pharmacol; 1989 Mar; 162(1):167-71. PubMed ID: 2566494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of in utero ethanol administration on the electrophysiological activity of rat nigrostriatal dopaminergic neurons.
    Shen RY; Chiodo LA
    Brain Res; 1993 Oct; 624(1-2):216-22. PubMed ID: 8252394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
    Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors.
    Pucak ML; Grace AA
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1181-92. PubMed ID: 7996424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological characteristics and pharmacological responsiveness of midbrain dopaminergic neurons of the aged rat.
    Freeman AS; Kelland MD; Rouillard C; Chiodo LA
    J Pharmacol Exp Ther; 1989 Jun; 249(3):790-7. PubMed ID: 2567352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous DA-mediated feedback inhibition of DA neurons: involvement of both D(1)- and D(2)-like receptors.
    Shi WX; Pun CL; Smith PL; Bunney BS
    Synapse; 2000 Feb; 35(2):111-9. PubMed ID: 10611636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.